US Stock MarketDetailed Quotes

KPRX Kiora Pharmaceuticals

Watchlist

3.7700
+0.0700+1.89%

Close Aug 23 16:00 ET

3.7500
-0.0200-0.53%

Post 20:02 ET

11.20MMarket Cap-651P/E (TTM)

Kiora Pharmaceuticals Stock Forum

Trytosaveabit

Jun 13 15:55

Insider buys

$Kiora Pharmaceuticals (KPRX.US)$ Officer Strem Brian M. purchased 3,000 shares of common stock on Jun 13, 2024 at an average price of $4.999 for a total value of $14,997.
Director Parsons Erin purchased 5,260 shares of common stock on Jun 13, 2024 at an average price of $4.88 for a total value of $25,668.8.

Trytosaveabit

Jun 10 19:01

Watching for post R/S movement??

$Kiora Pharmaceuticals (KPRX.US)$ In the world of R/S’s lately. This is gettin a baby R/S! Earnings was very nice and who knows? It hit ATL/52wk low on Friday.That makes a big ole bottom! Hehehe! Likes me some bottoms. Lets see if the higher price from R/S can actually bring some interest from the market in the next few day post R/S? Have vol/price alerts set. If i see a proper chart set up? Ill give it a shot if it presents!

TonyMan

May 10 07:34

$Kiora Pharmaceuticals (KPRX.US)$A parade of solid news but this stock does not pop. I guess institutions have not adopted this stock. I can only guess.

Jaguar8

May 6 06:05

$Kiora Pharmaceuticals (KPRX.US)$
NEWS
Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa

Trytosaveabit

Apr 11 06:32

Update

$Kiora Pharmaceuticals (KPRX.US)$ Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Thu, Apr 11, 2024
Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for pat...

Trytosaveabit

Mar 8 06:06

Update

$Kiora Pharmaceuticals (KPRX.US)$ Kiora Announces Publication of Phase 1 Study Demonstrating Safety, Tolerability and Anti-Inflammatory Activity of KIO-101 in the Treatment of Inflammation of the Eye
newsfile· 6 mins ago

71698595

Feb 5 09:13

$Kiora Pharmaceuticals (KPRX.US)$ very low volume, looks like people have lost interest in this.

71698595

Feb 2 12:25

$Kiora Pharmaceuticals (KPRX.US)$ looking good, slow and up

Tom2808

Feb 1 17:51

$Kiora Pharmaceuticals (KPRX.US)$ so sad

Trytosaveabit

Feb 1 14:35

For those that want a summary!

$Kiora Pharmaceuticals (KPRX.US)$ NASDAQ: KPRX) entered into an agreement with Théa Open Innovation SAS (TOI) concerning the KIO-301 molecular photoswitch product. According to the agreement, Kiora Pharmaceuticals has granted TOI an exclusive, sublicensable license to pursue development, manufacturing, commercialization, and regulatory approvals for the product globally, excluding specific Asian countries. The focus of the product’s use will be on treating retinitis ...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall